Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Spring Bank Pharmaceuticals, Inc. | 0 | reported | 08 Mar 2023 | tx 8+47,874−47,874 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 08 Mar 2023 | TENDER | Spring Bank Pharmaceuticals, Inc. | 3,937 | 7.12 USD | |
| 08 Mar 2023 | OTHER | Spring Bank Pharmaceuticals, Inc. | 20,000 | — | deriv |
| 08 Mar 2023 | OTHER | Spring Bank Pharmaceuticals, Inc. | 20,000 | — | deriv |
| 29 Jul 2022 | EXERCISE | Spring Bank Pharmaceuticals, Inc. | 3,937 | 0.11 USD | |
| 29 Jul 2022 | EXERCISE | Spring Bank Pharmaceuticals, Inc. | 3,937 | 0.00 USD | deriv |
| 17 Jun 2022 | GRANT_AWARD | Spring Bank Pharmaceuticals, Inc. | 20,000 | 0.00 USD | deriv |
| 04 Jun 2021 | GRANT_AWARD | Spring Bank Pharmaceuticals, Inc. | 20,000 | 0.00 USD | deriv |
| 20 Nov 2020 | GRANT_AWARD | Spring Bank Pharmaceuticals, Inc. | 3,937 | 0.00 USD | deriv |